Brief: Femasys’Femcerv Endocervical Tissue Sampler For Cervical Cancer Diagnosis Receives Product Approval In Canada
03/05/2023 13:52
May 3 (Reuters) - Femasys Inc FEMY.O :
* FEMASYS’ FEMCERV ENDOCERVICAL TISSUE SAMPLER FOR CERVICAL
CANCER
DIAGNOSIS RECEIVES PRODUCT APPROVAL IN CANADA
Source text for Eikon: ID:nGNX69T5cm
Further company coverage: FEMY.O
((Reuters.Briefs@thomsonreuters.com;))